Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Airsculpt Technologies ( (AIRS) ) just unveiled an update.
On May 7, 2025, AirSculpt Technologies held its annual meeting of stockholders where two Class I directors, Yogi Jashnani and Daniel Sollof, were elected for a three-year term. Additionally, Grant Thornton was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2025, indicating continued stability in the company’s governance and financial oversight.
Spark’s Take on AIRS Stock
According to Spark, TipRanks’ AI Analyst, AIRS is a Neutral.
Airsculpt Technologies is facing notable financial challenges, highlighted by declining revenue and profitability, and high leverage. While strategic initiatives from the earnings call show some promise, the stock’s technical indicators and valuation metrics remain weak. The company needs to address these financial and operational headwinds to improve investor confidence.
To see Spark’s full report on AIRS stock, click here.
More about Airsculpt Technologies
AirSculpt Technologies operates in the cosmetic surgery industry, focusing on providing minimally invasive body contouring procedures.
Average Trading Volume: 344,011
Technical Sentiment Signal: Sell
Current Market Cap: $134.9M
For an in-depth examination of AIRS stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue